Search Results - "Patera, Patrizia I"

Monogenic Diabetes Accounts for 6.3% of Cases Referred to 15 Italian Pediatric Diabetes Centers During 2007 to 2012 by Delvecchio, Maurizio, Mozzillo, Enza, Salzano, Giuseppina, Iafusco, Dario, Frontino, Giulio, Patera, Patrizia I, Rabbone, Ivana, Cherubini, Valentino, Grasso, Valeria, Tinto, Nadia, Giglio, Sabrina, Contreas, Giovanna, Di Paola, Rosa, Salina, Alessandro, Cauvin, Vittoria, Tumini, Stefano, d’Annunzio, Giuseppe, Iughetti, Lorenzo, Mantovani, Vilma, Maltoni, Giulio, Toni, Sonia, Marigliano, Marco, Barbetti, Fabrizio

“…An etiologic diagnosis of diabetes can affect the therapeutic strategy and prognosis of chronic complications. The aim of the present study was to establish…”
Get full text

Monogenic diabetes clinic (MDC): 3-year experience by Rapini, Novella, Patera, Patrizia I., Schiaffini, Riccardo, Ciampalini, Paolo, Pampanini, Valentina, Cristina, Matteoli M., Deodati, Annalisa, Bracaglia, Giorgia, Porzio, Ottavia, Ruta, Rosario, Novelli, Antonio, Mucciolo, Mafalda, Cianfarani, Stefano, Barbetti, Fabrizio

“…Aim In the pediatric diabetes clinic, patients with type 1 diabetes mellitus (T1D) account for more than 90% of cases, while monogenic forms represent about…”
Get full text

Correction to: Monogenic diabetes clinic (MDC): 3‑year experience by Rapini, Novella, Patera, Patrizia I., Schiaffini, Riccardo, Ciampalini, Paolo, Pampanini, Valentina, Cristina, Matteoli M., Deodati, Annalisa, Bracaglia, Giorgia, Porzio, Ottavia, Ruta, Rosario, Novelli, Antonio, Mucciolo, Mafalda, Cianfarani, Stefano, Barbetti, Fabrizio

Get full text

Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing? by Delvecchio, Maurizio, Salzano, Giuseppina, Bonura, Clara, Cauvin, Vittoria, Cherubini, Valentino, d’Annunzio, Giuseppe, Franzese, Adriana, Giglio, Sabrina, Grasso, Valeria, Graziani, Vanna, Iafusco, Dario, Iughetti, Lorenzo, Lera, Riccardo, Maffeis, Claudio, Maltoni, Giulio, Mantovani, Vilma, Menzaghi, Claudia, Patera, Patrizia I., Rabbone, Ivana, Reindstadler, Petra, Scelfo, Sabrina, Tinto, Nadia, Toni, Sonia, Tumini, Stefano, Lombardo, Fortunato, Nicolucci, Antonio, Barbetti, Fabrizio

Get full text

A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8) by Pozzilli, Paolo, Crinò, Antonino, Schiaffini, Riccardo, Manfrini, Silvia, Fioriti, Elvira, Coppolino, Giusy, Pitocco, Dario, Visalli, Natalia, Corbi, Stefania, Spera, Sabrina, Suraci, Concetta, Cervoni, Marco, Matteoli, Maria C, Patera, I Patrizia, Ghirlanda, Giovanni

“…In a pilot study, the metabolic effects of continuous subcutaneous insulin infusion (CSII) versus intensive subcutaneous insulin therapy (ISIT) started at…”
Get more information

Monogenic diabetes clinic (MDC): 3-year experience (Sept, 10.1007/s00592-022-01972-2, 2022) by Rapini, N, Patera, PI, Schiaffini, R, Ciampalini, P, Pampanini, V, Cristina, MM, Deodati, A, Bracaglia, G, Porzio, O, Ruta, R

Get full text

Emerging Effects of Early Environmental Factors over Genetic Background for Type 1 Diabetes Susceptibility: Evidence from a Nationwide Italian Twin Study by Nisticò, Lorenza, Iafusco, Dario, Galderisi, Alfonso, Fagnani, Corrado, Cotichini, Rodolfo, Toccaceli, Virgilia, Stazi, Maria Antonietta, the Study Group on Diabetes of the Italian Society of Pediatric Endocrinology and Diabetology

“…Context: The incidence of type 1 diabetes has been increasing over time. Objective: We estimated the genetic and environmental components of type 1 diabetes…”
Get full text

Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy by Chianelli, M., Parisella, M. G., Visalli, N., Mather, S. J., D'Alessandria, C., Pozzilli, P., Signore, A.

“…Background To evaluate the clinical utility of pancreatic scintigraphy with 99mTc‐interleukin‐2 to identify Type 1 diabetic patients with pancreatic…”
Get full text

Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function by Pitocco, D, DiStasio, E, Crinò, A, Manfrini, S, Guglielmi, C, Visalli, N, Suraci, C, Matteoli, M C, Cavallo, M G, Bizzarri, C, Pozzilli, P

Get more information